What is the next step in management for a 37-week pregnant patient with a fundal height corresponding to 35 weeks and absent end-diastolic flow on umbilical artery Doppler (ultrasound)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 31, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Fetal Growth Restriction with Absent End-Diastolic Flow at 37 Weeks

Immediate delivery by cesarean section (Option B) is the appropriate next step for this 37-week pregnancy with fetal growth restriction and absent end-diastolic flow on umbilical artery Doppler. 1, 2

Why Immediate Cesarean Delivery is Mandatory

The patient is already past the recommended delivery threshold, as multiple guidelines recommend delivery by 33-34 weeks for absent end-diastolic flow, making this a high-risk scenario requiring urgent intervention. 1, 2

  • Absent end-diastolic flow indicates severe placental insufficiency with obliteration of approximately 70% of placental tertiary villi arteries, representing extreme fetal compromise 2
  • The fetus cannot tolerate the stress of labor contractions given this degree of placental dysfunction, with 75-95% of growth-restricted pregnancies with absent end-diastolic flow requiring emergency cesarean delivery for intrapartum heart rate abnormalities 1
  • International guidelines uniformly recommend delivery by 37 weeks when abnormal umbilical artery Doppler is present, and this patient has already reached that threshold 3

Why Induction of Labor is Contraindicated

  • Cesarean delivery should be strongly considered (rather than induction) for fetal growth restriction complicated by absent end-diastolic flow, as these fetuses cannot tolerate uterine contractions 2, 4
  • If end-diastolic flow is present (which it is not in this case), induction with continuous fetal monitoring could be considered, but absent flow mandates cesarean delivery 3

Why Delayed Delivery is Inappropriate

  • Delaying delivery by one week (Option C) is dangerous, as absent end-diastolic flow is associated with perinatal mortality rates of 60-63% when delivery is delayed 5, 6
  • The Society for Maternal-Fetal Medicine recommends delivery at 33-34 weeks for absent end-diastolic flow; at 37 weeks, this patient is already 3-4 weeks beyond the recommended delivery window 1, 2
  • Research demonstrates that absent end-diastolic flow always precedes fetal distress, and immediate delivery is indicated once this finding appears 7

Critical Pre-Delivery Actions

  • Coordinate with neonatology for optimal resuscitation planning, as these infants are at high risk for respiratory distress syndrome, necrotizing enterocolitis, and intraventricular hemorrhage 2, 8
  • Antenatal corticosteroids are not indicated at 37 weeks (only recommended up to 36+6 weeks), so this should not delay delivery 3, 1
  • Magnesium sulfate for neuroprotection is not indicated, as this is only recommended before 32 weeks gestation 1, 4

Essential Post-Delivery Management

  • Obtain cord arterial and venous pH at delivery to assess the degree of fetal compromise 1, 4
  • Send the placenta for histopathologic examination to guide future pregnancy management 1, 4

Common Pitfalls to Avoid

  • Do not attempt labor induction or augmentation with absent end-diastolic flow, as the severe placental compromise makes the fetus unable to tolerate contractions 4
  • Do not confuse absent end-diastolic flow with reversed end-diastolic flow (which is even more severe and has mortality rates exceeding 60%) 7, 5
  • Do not delay delivery for additional testing or surveillance at this gestational age, as the patient is already term and the risk of intrauterine fetal demise is substantial 2, 6

References

Guideline

Urgent Cesarean Section for Fetal Distress

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Fetal Growth Restriction and Absent End-Diastolic Flow Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of SGA Fetus with Reversed End-Diastolic Flow

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Significance of an absent or reversed end diastolic flow in Doppler umbilical artery waveforms.

Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine, 1987

Research

The clinical significance of absent or reverse end-diastolic flow in the fetal aorta and umbilical artery.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology, 1991

Related Questions

What is the best course of action for a pregnant woman at 35 weeks of gestation with a fundal height corresponding to 29 weeks and absent end-diastolic flow on umbilical artery Doppler (ultrasound of the umbilical artery)?
What is the best course of action for a 35-week pregnant woman with a fundal height corresponding to 29 weeks and absent end-diastolic flow on umbilical artery Doppler?
What is the management for a primigravida (first-time pregnant woman) at 37 weeks gestation with severe hypertension, irritated state, and absent end diastolic flow?
What is the recommended course of action for a fetus with absent end diastolic flow on the umbilical artery (UA)?
What is the most appropriate management for a patient at 33 weeks' gestation with a small for gestational age (SGA) fetus and reversed end-diastolic flow on umbilical artery Doppler?
What is anaphylaxis, including its causes, symptoms, and treatment in patients with a history of allergies or previous anaphylactic episodes?
How should a patient on BiPAP (Bilevel Positive Airway Pressure) with alkalosis, hypocapnia, and hypoxemia be managed?
How do you manage congestive hepatitis with underlying heart failure and potential liver disease complications?
How do you manage congestive hepatitis with underlying heart failure and potential liver disease complications?
What is the appropriate initial approach for a 17-year-old male with a 2-week history of productive cough and no other symptoms?
How do you manage congestive hepatitis with underlying heart failure and potential liver disease complications?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.